Published in Ann Oncol on May 01, 2006
Human-mouse genome comparisons to locate regulatory sites. Nat Genet (2000) 8.08
End-of-life decisions in neonatal intensive care: physicians' self-reported practices in seven European countries. EURONIC Study Group. Lancet (2000) 4.01
Treatment choices for extremely preterm infants: an international perspective. J Pediatr (2000) 2.19
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol (1995) 1.71
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res (2000) 1.71
Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res (2005) 1.65
Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab (1998) 1.63
A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol Motil (2007) 1.56
The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings. Arch Intern Med (2000) 1.50
Cushing's syndrome. Lancet (2001) 1.48
Human cytomegalovirus and restenosis of the internal carotid artery. Stroke (1996) 1.43
Clinical application of the Biotrack 516 system for determination of theophylline by a turbidimetric latex agglutination inhibition reaction. Ther Drug Monit (1996) 1.39
Early and rapid diagnosis of CMV infection by nonradioactive in situ hybridization in pediatric kidney transplant recipients. Nephron (1992) 1.39
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer. Eur J Cancer (1993) 1.38
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. J Med Chem (1996) 1.29
West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill (2009) 1.18
Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest (1995) 1.10
Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol (1997) 1.10
Quinolone binding to DNA is mediated by magnesium ions. Proc Natl Acad Sci U S A (1992) 1.10
Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol (2012) 1.09
Growth charts, growth velocity and bone development in childhood obesity. Int J Obes Relat Metab Disord (1995) 1.06
6-Aminoquinolones as new potential anti-HIV agents. J Med Chem (2000) 1.05
Separation methods for acyclovir and related antiviral compounds. J Chromatogr B Biomed Sci Appl (2001) 1.04
Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev Med Virol (2009) 1.04
The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill (2015) 1.04
The effect of the minor groove binding agent DAPI (4,6-diamidino-2-phenyl-indole) on DNA-directed enzymes: an attempt to explain inhibition of plasmid expression in Escherichia coli [corrected]. FEMS Microbiol Lett (1990) 1.03
Genome sequence analysis of the first human West Nile virus isolated in Italy in 2009. Euro Surveill (2009) 1.03
Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1999) 1.03
Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential. Curr Med Chem (2009) 1.02
Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers. Int J Clin Pharmacol Ther (1994) 1.01
Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein--infused rats. J Neurochem (1996) 0.99
Synthesis and biological evaluation of N6-cycloalkyl derivatives of 1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents. J Med Chem (1995) 0.97
On the mechanism of action of quinolone drugs. Trends Microbiol (1993) 0.96
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Cancer Res (2001) 0.96
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut (2006) 0.96
Pyrrolo-quinoline derivatives as potential antineoplastic drugs. Bioorg Med Chem (2000) 0.95
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.95
Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur J Endocrinol (2002) 0.95
Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill (2012) 0.94
Quality of life in shift work syndrome. Funct Neurol (1997) 0.94
Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab (2001) 0.94
The effects of metal ions on the structure and stability of the DNA gyrase B protein. J Mol Biol (2005) 0.94
Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions. J Mol Biol (2001) 0.94
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol (2011) 0.94
HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum. Sex Transm Infect (2000) 0.93
Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome. Minerva Ginecol (2014) 0.92
Do quinolones bind to DNA? Biochem Pharmacol (1988) 0.92
Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol (1992) 0.92
Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol (2001) 0.92
Solid-state infrared absorption spectra and chain arrangement in some synthetic homooligopeptides in the intermolecularly hydrogen-bonded pleated-sheet beta-conformation. Biopolymers (1977) 0.91
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. J Acquir Immune Defic Syndr (1999) 0.91
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci (2011) 0.91
Sequence specificity of psoralen photobinding to DNA: a quantitative approach. Biochemistry (1992) 0.90
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. Mol Pharmacol (1995) 0.90
Rapid diagnosis of influenza type A infection: comparison of shell-vial culture, directigen flu-A and enzyme-linked immunosorbent assay. New Microbiol (1996) 0.90
Unexplained infertility and ovulatory induction with menopausal gonadotropins. Minerva Ginecol (2014) 0.90
The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage. Nucleic Acids Res (2001) 0.90
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120. Gene Ther (2005) 0.90
Novel pyrrolo[3,2-f]quinolines: synthesis and antiproliferative activity. Bioorg Med Chem (2001) 0.90
Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther (2005) 0.90
Ovulation induction with clomiphene citrate for infertile couple. Minerva Ginecol (2014) 0.89
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol (2005) 0.89
Irreversible and reversible topoisomerase II DNA cleavage stimulated by clerocidin: sequence specificity and structural drug determinants. Cancer Res (1997) 0.89
Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage. J Mol Biol (1994) 0.88
Dinuclear Zn(2+) complexes of synthetic heptapeptides as artificial nucleases. J Am Chem Soc (2001) 0.88
Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection (2008) 0.88
Measles in Italy, July 2009 to September 2010. Euro Surveill (2011) 0.88
On the oxy analogues to the 4 leads to 1 intramolecularly hydrogen-bonded peptide conformations. Macromolecules (1976) 0.87
Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid. Biochem Pharmacol (1988) 0.87
The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region. Virology (2000) 0.87
Inhibitors of HIV-1 Tat-mediated transactivation. Curr Med Chem (2006) 0.87
Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line. Endocr Res (1996) 0.87
Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sci (2003) 0.87
Simultaneous polymerase chain reaction detection and restriction typing for the diagnosis of human genital papillomavirus infection. J Virol Methods (1995) 0.87
Outbreak of serogroup C meningococcal disease in Veneto region, Italy. Euro Surveill (2008) 0.86
Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? Curr Med Chem (2009) 0.86
Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB. Antimicrob Agents Chemother (2009) 0.86
Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses (2008) 0.86
Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit. Proc Natl Acad Sci U S A (1994) 0.86
Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Eur J Endocrinol (2001) 0.86
Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009. Euro Surveill (2011) 0.86
Liquid-crystalline structure of nucleic acids: effect of antracycline drugs and copper ions. J Biomol Struct Dyn (1997) 0.86
Accurate human papillomavirus genotyping by 454 pyrosequencing. Clin Microbiol Infect (2013) 0.86
Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther (2006) 0.86
Oncolysis of pancreatic tumour cells by a gamma34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathway. Gene Ther (2006) 0.85
Mg(2+)-mediated binding of 6-substituted quinolones to DNA: relevance to biological activity. Bioorg Med Chem (1998) 0.85
A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. Trends Pharmacol Sci (1997) 0.84
Novel West Nile virus lineage 1a full genome sequences from human cases of infection in north-eastern Italy, 2011. Clin Microbiol Infect (2012) 0.84
Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients. Antimicrob Agents Chemother (1991) 0.84
Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation. J Mol Endocrinol (2005) 0.84
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. J Clin Endocrinol Metab (1998) 0.84
West Nile virus: the Italian national transplant network reaction to an alert in the north-eastern region, Italy 2011. Euro Surveill (2011) 0.84
Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line. Chemotherapy (1998) 0.84